L1Z1 Stock Overview
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Alphatec Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.70 |
| 52 Week High | US$16.60 |
| 52 Week Low | US$8.20 |
| Beta | 1.46 |
| 1 Month Change | -5.65% |
| 3 Month Change | -20.41% |
| 1 Year Change | -12.03% |
| 3 Year Change | -10.00% |
| 5 Year Change | 238.35% |
| Change since IPO | 385.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| L1Z1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.7% | 1.7% | 1.7% |
| 1Y | -12.0% | -7.7% | 2.3% |
Price Volatility
| L1Z1 volatility | |
|---|---|
| L1Z1 Average Weekly Movement | 7.8% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 839 | Pat Miles | www.atecspine.com |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
Alphatec Holdings, Inc. Fundamentals Summary
| L1Z1 fundamental statistics | |
|---|---|
| Market cap | €1.64b |
| Earnings (TTM) | -€173.98m |
| Revenue (TTM) | €449.56m |
3.5x
P/S Ratio-9.0x
P/E RatioIs L1Z1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L1Z1 income statement (TTM) | |
|---|---|
| Revenue | US$482.26m |
| Cost of Revenue | US$172.06m |
| Gross Profit | US$310.20m |
| Other Expenses | US$496.84m |
| Earnings | -US$186.64m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -1.35 |
| Gross Margin | 64.32% |
| Net Profit Margin | -38.70% |
| Debt/Equity Ratio | 504.2% |
How did L1Z1 perform over the long term?
See historical performance and comparison